Assignee
ZHANG ZUOGUANG
CN·6 granted patents·6 pending applications·0 citations·filing 2005–2020
Top patents by PatentIndex Score
12 records- 0150US2019336519A1Application of albiflorin as indoleamine 2,3-dioxygenase (ido) inhibitorZHANG ZUOGUANG·Filed 2017·Application pending·0 cites
- 0250US2010310682A1Pharmaceutical compositions for treating anxietyZHANG ZUOGUANG·Filed 2007·Application pending·0 cites
- 0350US2010310683A1Pharmaceutical compositions for treating depression and anxietyZHANG ZUOGUANG·Filed 2007·Application pending·0 cites
- 0450US2023095701A1Use of Albiflorin in Treatment of Coronavirus PneumoniaZHANG ZUOGUANG·Filed 2020·Application pending·0 cites
- 0548US9023817B2Use of albiflorin for anti-depressionZHANG ZUOGUANG·Filed 2010·Granted May 5, 2015·0 cites·3 claims
- 0645US11020415B2Use of albiflorin in preparation of products for improving function of intestinal flora systemZHANG ZUOGUANG·Filed 2017·Granted Jun 1, 2021·0 cites·8 claims
- 0745US2009232914A1Pharmaceutical composition for treating depression and method for preparation thereofZHANG ZUOGUANG·Filed 2005·Application pending·0 cites
- 0844US8889650B2Antimelancholic medicine prepared with jujube camp materialsZHANG ZUOGUANG·Filed 2007·Granted Nov 18, 2014·0 cites·3 claims
- 0942US9555055B2Use of albiflorin and metabolites thereofZHANG ZUOGUANG·Filed 2011·Granted Jan 31, 2017·0 cites·4 claims
- 1042US2017274032A1Pharmaceutical compositions for treating anxietyZHANG ZUOGUANG·Filed 2017·Application pending·0 cites
- 1136US10350230B2Use of albiflorin or pharmaceutically acceptable salt for prevention and/or treatment of irritable bowel syndromeZHANG ZUOGUANG·Filed 2015·Granted Jul 16, 2019·0 cites·7 claims
- 1233US9453041B2Method for preparing albiflorin and paeoniflorinZHANG ZUOGUANG·Filed 2010·Granted Sep 27, 2016·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when ZHANG ZUOGUANG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →